Skip to main content
. 2017 May 30;42(4):262–272. doi: 10.1503/jpn.160136

Table 1.

Demographic and clinical characteristics of participants

Group; no. or mean ± SD

Characteristic Schizophrenia (n = 27) Control (n = 21) Statistical comparison p value
Sex, male:female 23:4 17:4 χ2 = 0.151 p = 0.70
Age, yr 29.7 ± 8.6 29.2 ± 7.9 t = −0.198 p = 0.84
Parental socioeconomic status* 45.8 ± 15.5 41.6 ± 14.9 t = −0.922 p = 0.36
IQ 99.9 ± 15.2 109.3 ± 15.4 t = 2.121 p = 0.039
Schizophrenia:schizoaffective disorder 18:9
Illness duration, yr 7.6 ± 7.9
Antipsychotic medication, atypical:typical:atypical + typical 24:0:3
Chlorpromazine equivalent, mg 547.7 ± 474.7
PANSS
 Positive 13.8 ± 6.5
 Negative 16.0 ± 6.3
 Cognitive/disorganization 9.6 ± 3.0
 Depression/anxiety 8.5 ± 3.1
 Excitement/hostility 6.6 ± 3.0
SOFI§
 Living situation 74.3 ± 16.4
 Instrumental activities of daily living 68.1 ± 17.5
 Productive activities and role functioning 44.1 ± 26.7
 Social functioning 59.7 ± 16.4

PANSS = Positive and Negative Syndrome Scale; SD = standard deviation; SOFI = Schizophrenia Objective Functioning Instrument.

*

Assessed using the Hollingshead index.

Assessed using the matrix reasoning and the vocabulary subtests of the Wechsler Adult Intelligence Scale – Fourth Edition.

Five-factor model by Lehoux and colleagues.41

§

Data available for 26 patients.